These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21047201)

  • 1. Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer.
    Sakano S; Hinoda Y; Sasaki M; Wada T; Matsumoto H; Eguchi S; Shinohara A; Kawai Y; Hara T; Nagao K; Hara T; Naito K; Matsuyama H
    Pharmacogenomics; 2010 Oct; 11(10):1377-87. PubMed ID: 21047201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.
    Sakano S; Wada T; Matsumoto H; Sugiyama S; Inoue R; Eguchi S; Ito H; Ohmi C; Matsuyama H; Naito K
    Br J Cancer; 2006 Sep; 95(5):561-70. PubMed ID: 16880786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
    Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Sun Y; Xu BH; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):972-5. PubMed ID: 16061005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
    Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
    Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
    El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
    Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.
    Yu SN; Liu GF; Li XF; Fu BH; Dong LX; Zhang SH
    J Cell Biochem; 2017 Dec; 118(12):4782-4791. PubMed ID: 28520216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
    Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
    Kietthubthew S; Sriplung H; Au WW; Ishida T
    Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.
    Ryk C; Kumar R; Sanyal S; de Verdier PJ; Hemminki K; Larsson P; Steineck G; Hou SM
    Cancer Lett; 2006 Sep; 241(1):142-9. PubMed ID: 16343742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.